Health
People with brain aneurysms at higher risk of some mental health disorders, study finds
People who have been diagnosed with a brain aneurysm may be more susceptible to certain mental health conditions, according to a study published by the American Heart Association (AHA).
The knowledge of an unruptured aneurysm increased the risk of anxiety, stress, depression, insomnia, bipolar disorder, eating disorders, and alcohol or drug misuse by 10% over a 10-year period, the researchers found.
An unruptured aneurysm occurs when a blood vessel in the brain becomes weak and bulges out — creating the risk of a potentially deadly rupture, per the AHA.
RUPTURED BRAIN ANEURYSM LANDS SOCIAL MEDIA INFLUENCER IN MEDICALLY INDUCED COMA AFTER EMERGENCY C-SECTION
The effect was most seen in adults under 40 years of age, and the risk was three times greater among those who received an official mental health diagnosis.
The researchers analyzed data for 85,438 adults with untreated aneurysms between 2011 and 2019, comparing them to 331,000 adults without aneurysms.
An unruptured aneurysm occurs when a blood vessel in the brain becomes weak and bulges out, creating the risk of a potentially deadly rupture. (American Heart Association)
The data came from the National Health Information Database in South Korea.
The findings were published in Stroke, the peer-reviewed scientific journal of the American Stroke Association, a division of the AHA.
MICHIGAN MOM: ‘I HAD A STROKE AT 39 — AND THE WARNING SIGNS WEREN’T WHAT YOU’D EXPECT’
“As a neurosurgeon who treats cerebral aneurysms, I often see people who do not undergo surgery, yet feel fear and/or anxiety about their condition before each imaging or screening test to monitor their condition,” said study co-author Na-Rae Yang, M.D., PhD, an assistant professor of neurosurgery in the department of neurosurgery at Ewha Womans University College of Medicine in Seoul, South Korea, in a press release.
“Even when it is medically judged and explained that follow-up observation is the best course for their aneurysm rather than surgery, they still worry about the very slim chance of developing a fatal brain bleed.”
The fact that younger adults were more likely to have a “significant psychological burden” could be linked to other life stressors, an expert noted. (iStock)
The fact that younger adults were more likely to have a “significant psychological burden” could be linked to other life stressors, Yang noted, such as building their career and/or raising a family.
“This elevated rate of mental health conditions suggests that younger people might be particularly vulnerable, highlighting the need for targeted mental health support and interventions for this age group,” she added.
TIAS AND MINI-STROKE RISKS: CARDIOLOGIST SHARES WARNING SIGNS AND PREVENTION TIPS
Dr. Daniel T. Lackland, an American Heart Association EPI and Stroke Council member and professor of epidemiology at the Medical University of South Carolina, was not involved in the study but said he was not surprised by the findings.
“While there is no evidence that aneurysms directly cause anxiety and mental disorders, this study suggests there may be a connection between stress and aneurysms, and that unruptured aneurysms can increase emotional distress,” he told Fox News Digital.
The knowledge of an unruptured aneurysm increased the risk of anxiety, stress, depression, insomnia, bipolar disorder, eating disorders, and alcohol or drug misuse by 10% over a 10-year period, the researchers found. (iStock)
“For example, an enlarging aneurysm may physically affect nearby sympathetic ganglia, which could produce panic or anxiety symptoms.”
Extreme emotional stress could also increase the risk of an enlarged aneurysm rupturing, which could increase anxiety, Lackland added.
ANGER CAN INCREASE HEART ATTACK RISK, STUDY FINDS: ‘CHRONIC INSULT TO ARTERIES’
Based on the findings, Lackland recommends maintaining active and regular communication with health providers, particularly for individuals with a family history of brain aneurysms.
“If diagnosed with a brain aneurysm, [the patient should] follow through with the appropriate and proper treatment,” he advised.
“Brain aneurysms, like aortic aneurysms, are life-threatening if they rupture, but can be treated with appropriate therapy and/or procedures.”
Although the findings suggest an association between aneurysms and mental health conditions, they can’t prove cause and effect, the researchers noted. (iStock)
Dr. Bradley Serwer, a cardiologist and chief medical officer at VitalSolution, a Cincinnati-based company that offers cardiovascular and anesthesiology services to hospitals nationwide, has also noticed this phenomenon in his own practice.
“Whether the patient is told they have a brain aneurysm or they have an abnormal heart valve, irregular heart rhythm or aortic aneurysm, the psychological ramifications are significant,” Serwer, who was not involved in the research, told Fox News Digital.
Younger patients may have fewer coping mechanisms, he noted.
“They tend to perseverate more on the medical conditions, and this can lead to anxiety.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
This study highlights the importance of taking a multidisciplinary approach to patient care, Serwer said, as well as the “dramatic need” for more behavioral and mental health services to support these individuals.
Potential limitations
The study did have some limitations, the researchers acknowledged.
The analysis relied on a national database of medical codes rather than input from individual patients.
“Brain aneurysms, like aortic aneurysms, are life-threatening if they rupture, but can be treated with appropriate therapy and/or procedures.”
Additionally, the research did not take into account the size or location of the aneurysms.
Although the findings suggest an association between aneurysms and mental health conditions, they can’t prove cause and effect, the researchers noted.
For more Health articles, visit www.foxnews/health
“As the authors indicate, there is inadequate evidence to indicate that brain aneurysms cause increased mental health risks,” said Lackland.
“Also, the study was done in Korea — and it is unclear if the results can be generalized to other populations.”
Health
4 Mistakes People Make When Starting a GLP-1 That Can Stall Weight Loss—Plus How to Maximize Your Results
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
NEWYou can now listen to Fox News articles!
With an aggressive new strain spreading across the country, this year’s flu season has been marked by record-high hospitalizations and reportedly intense symptoms.
As people look for ways to contain the spread, new research has found that a few simple factors can greatly reduce transmission.
Researchers from the University of Maryland Schools of Public Health and Engineering in College Park and the School of Medicine in Baltimore studied influenza spread by placing flu-positive college students in a hotel room with healthy middle-aged adult volunteers.
FLU HOSPITALIZATIONS HIT ALL-TIME WEEKLY HIGH IN DENSELY POPULATED STATE, OFFICIALS WARN
The study, published in the journal PLOS Pathogens, is reportedly the first clinical trial investigating how the flu spreads from naturally infected people to uninfected people, according to a press release.
The participants, including 11 healthy volunteers, lived on a quarantined floor of a Baltimore-area hotel for two weeks. During that time, they simulated interactions, including having conversations, doing physical activities like yoga, and passing around objects like pens and tablets from infected people to the rest of the group.
New research has experts questioning how the flu spreads through airborne transmission. (iStock)
Researchers monitored the participant’s symptoms, performed daily nasal swabs, and collected saliva and blood samples to test for antibodies, the release stated.
The study also measured the “viral exposure” in the volunteers’ breathing air and ambient air in the activity room. The exhaled breath of the participants was measured by a machine called the Gesundheit II, invented by researcher Dr. Donald Milton and colleagues at Harvard T.H. Chan School of Public Health.
COULD DENTAL FLOSS BE THE NEXT VACCINE METHOD? SCIENTISTS SAY IT COULD WORK
At the end of the experiment, none of the healthy individuals had become infected with the flu due to a variety of factors. This included a lack of coughing, as the infected students were holding “a lot of virus in their noses” and only small amounts were “expelled into the air,” the researchers noted.
Researchers said proper ventilation was a major factor in halting flu spread in this study. (iStock)
“Our data suggests key things that increase the likelihood of flu transmission — coughing is a major one,” Dr. Jianyu Lai, post-doctoral research scientist and the study’s lead data analyst and report writer, shared in a statement.
CLICK HERE FOR MORE HEALTH STORIES
The other factor was ventilation and air movement, as the air in the study room was “continually mixed rapidly by a heater and dehumidifier, and so the small amounts of virus in the air were diluted,” Lai pointed out.
The researcher added that middle-aged adults are “usually less susceptible” to influenza than younger adults.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Most researchers assume that airborne transmission is a major factor of disease spread, according to Dr. Donald Milton, professor at SPH’s Department of Global, Environmental and Occupational Health and a global infectious disease aerobiology expert.
“At this time of year, it seems like everyone is catching the flu virus, and yet our study showed no transmission,” he said in the same press release. “What does this say about how flu spreads and how to stop outbreaks?”
There have been 81,000 flu-related hospitalizations and more than 3,000 deaths in the U.S. this year so far, data shows. (iStock)
Milton, who was reportedly among the first experts to identify how to stop the spread of COVID-19, noted that findings from these types of trials are essential to updating international infection-control guidelines.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“Being up close, face-to-face with other people indoors where the air isn’t moving much, seems to be the most risky thing — and it’s something we all tend to do a lot,” he said.
“At this time of year, it seems like everyone is catching the flu virus, and yet our study showed no transmission.”
“Our results suggest that portable air purifiers that stir up the air, as well as clean it, could be a big help,” Milton suggested. “But if you are really close and someone is coughing, the best way to stay safe is to wear a mask, especially the N95.”
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Approximately 11 million flu illnesses and about 5,000 deaths have occurred so far in the 2025-2026 influenza season, according to CDC data. A large share of the current flu cases are caused by the new influenza A subclade K variant.
NEWYou can now listen to Fox News articles!
GLP-1 has become a popular buzzword in the weight-loss community — but now some are touting “GLP-3s,” claiming they are taking obesity medications to the next level.
GLP-1 (glucagon-like peptide-1) medications work by mimicking a naturally occurring hormone in the body that helps regulate blood sugar and appetite.
The informal term “GLP-3” refers to a new triple-agonist drug that targets three hormones: GLP-1, GIP (glucose-dependent insulinotropic polypeptide, another naturally occurring hormone released by the gut after eating) and glucagon receptors. The most advanced example is retatrutide by Eli Lilly, according to clinical trial outcomes.
OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU
The New England Journal of Medicine published results from a 2023 phase 2 retatrutide trial for obesity, revealing “substantial reductions in body weight” after 48 weeks of treatment.
A 12 mg once-weekly injection led to a 24.2% weight reduction, and participants continued to drop pounds after the 48-week trial period.
GLP-1 (glucagon-like peptide-1) medications work by mimicking a naturally occurring hormone in the body that helps regulate blood sugar and appetite. (iStock)
Side effects were reportedly similar to GLP-1 medications, most commonly including gastrointestinal complications like nausea, vomiting and diarrhea. Heart rate increases were noted, depending on the dose.
How it’s different
Retatrutide mimics three natural hormones found in the body, compared to GLP-1s that simulate just one hormone, according to a report by GoodRx pharmacists.
GIP and GLP-1 hormones signal the pancreas to release insulin after eating, while slowing digestion to help initiate feelings of fullness.
NEW WEGOVY PILL OFFERS NEEDLE-FREE WEIGHT LOSS — BUT MAY NOT WORK FOR EVERYONE
These hormones target the area of the brain that regulates appetite and influences food cravings, the report noted.
The third hormone, glucagon, speeds up metabolism and helps the body break down fat cells for energy. That hormone also tells the liver to make new sugar, which is kept in check by GIP and GLP-1 activity, preventing blood sugar spikes.
Participants in the phase 3 trial saw an average weight loss of 71.8 pounds. (iStock)
“This added metabolism boost can add to and complement GIP’s and GLP-1’s actions. And that’s why it seems to provide significant weight loss,” the GoodRx website states. “If approved, retatrutide will be the first in a new class of medications.”
Eli Lilly announced results from its phase 3 trial TRIUMPH-4 in December, testing retatrutide’s effect on weight loss and other health conditions.
“We believe retatrutide could become an important option for patients with significant weight loss needs and certain complications.”
Participants with obesity and knee arthritis who took a 12-mg dose of retatrutide saw an average weight loss of 71.8 lbs (28.7%) at 68 weeks.
“For retatrutide, the findings from TRIUMPH-4 are encouraging, and with seven additional phase 3 readouts expected in 2026, we believe retatrutide could become an important option for patients with significant weight loss needs and certain complications, including knee osteoarthritis,” a Lilly spokesperson said in a statement to Fox News Digital.
CLICK HERE FOR MORE HEALTH STORIES
The drug also reduced Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain scores by an average of 75.8%, marking “significant improvements” in comfort level and physical function.
More than one in eight patients reported being “completely free” from knee pain at the end of the trial, according to a press release from Lilly.
Participants with obesity and knee arthritis who took a 12-mg dose of retatrutide saw an average weight loss of 71.8 lbs (28.7%) at 68 weeks. (iStock)
Seven additional phase 3 trials for retatrutide are expected to wrap up in 2026. The drug could see FDA approval in 2027, according to GoodRx.
The Lilly spokesperson noted that there have been no studies comparing retatrutide to GLP-1 treatments due to “differences in study design and patient populations.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Despite limited data availability on the drug, the medication could also be applied to treat other conditions like type 2 diabetes, kidney disease, cardiovascular risk reduction and metabolic dysfunction, according to GoodRx and other experts.
Fox News senior medical analyst Dr. Marc Siegel noted that Lilly’s Zepbound and Mounjaro already target two metabolic pathways — GLP-1 and GIP — which work together to promote weight loss, reduce hunger and inflammation, improve insulin function and slow digestion.
The doctor confirmed that the new drug, with its third receptor agonist, will further decrease hunger while increasing the feeling of fullness.
More than one in eight patients reported being “completely free” from knee pain at the end of the trial. (iStock)
“The weight loss in clinical trials is even more substantial, and the most likely reason that it decreases orthopedic problems is because of the weight loss — less stress on the joints and the decreased inflammation,” Siegel added.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The most common side effect of GLP-3s is gastrointestinal symptoms, the doctor confirmed. Rarer side effects may include pancreatitis, gallstones and heart arrhythmia.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Philip Rabito, M.D., a specialist in endocrinology, weight loss and wellness in New York City, shared in an interview with Fox News Digital that this new class of weight-loss drugs is positioned to “approach bariatric surgery level outcomes” — although it doesn’t come without risks.
“The novel glucagon‑agonist component introduces less‑understood long‑term safety considerations, so it is imperative that patients are followed closely by healthcare professionals experienced with this class of medicines, with cautious, stepwise use, despite the impressive efficacy,” he cautioned.
The cheese stands alone: Exploring the world of CT cheese
Delaware Sen. Chris Coons leading congressional delegation to Greenland as Trump threatens takeover
Cruise ship out of Florida hit by norovirus outbreak; 94 affected
Seaside Georgia Announces Strategic Expansion of Portfolio to Meet Growing International Demand for Black Sea Real Estate
2026 Sony Open in Hawaii payout, purse: How much does each golfer get?
Florida High School Football Rankings: Top 25 teams – Oct. 21
Cleary's 21 help Le Moyne down Central Connecticut State 69-64 in OT
How old is Bo Nix? What to know about Oregon quarterback ahead of 2024 NFL Draft
99th annual Pony Swim held in Virginia
Video: ‘It Didn’t Have to Happen This Way:’ U.Va. Faculty Call for Review of Police Response to Protests
Rep Ro Khanna demands prosecution of ICE agent in Minneapolis fatal shooting
Syrian army sends troops to rural Aleppo to stop any SDF attempt to regroup
Iran acknowledges mass protest deaths, but claims situation under control as Trump mulls response
The Mayor of London explains why he thinks London is getting safer | BBC Newscast
Video: What Our Photographer Saw in Minneapolis
-
Detroit, MI1 week ago2 hospitalized after shooting on Lodge Freeway in Detroit
-
Technology7 days agoPower bank feature creep is out of control
-
Dallas, TX4 days agoAnti-ICE protest outside Dallas City Hall follows deadly shooting in Minneapolis
-
Delaware4 days agoMERR responds to dead humpback whale washed up near Bethany Beach
-
Montana3 days agoService door of Crans-Montana bar where 40 died in fire was locked from inside, owner says
-
Dallas, TX1 week agoDefensive coordinator candidates who could improve Cowboys’ brutal secondary in 2026
-
Iowa7 days agoPat McAfee praises Audi Crooks, plays hype song for Iowa State star
-
Virginia3 days agoVirginia Tech gains commitment from ACC transfer QB